Wiley AI Access Timeline
Reviewed Strategic Signal records on Wiley’s AI access relationships, rights, and disclosed economics.
These selected timelines include reviewed registry records with an exact company name or a source-verified participant label. A product, affiliate, or parent name alone does not establish participation. Coverage reflects Strategic Signal’s research sample. Records are ordered by original announcement date. A record may reflect later amendments or evidence updates.
Mar 3, 2026 · Data-rights qualified
Wiley → OpenEvidence
Wiley scientific and medical journals, books, Cochrane systematic reviews and Clinical Answers licensed into OpenEvidence's cited clinical-answer evidence layer.
Wiley role · Provider / asset owner
- Provider / asset owner — Wiley, Cochrane content licensed through Wiley
- AI recipient — OpenEvidence
- Strategic buyer or operator — OpenEvidence
Recorded status · announced historical backfill. Last reviewed Nov 18, 2026.
Access · retrieval. Training rights · not disclosed.
Disclosed economics · No arrangement-specific consideration established in the inspected announcement. Scope · No data-license value is estimated. Aggregate corporate revenue, financing valuations, settlement payments and catalogue capacity are not treated as this arrangement’s price.
Evidence
Jun 17, 2025 · Data-rights qualified
Wiley → Undisclosed third large technology company
Wiley content subject to the third large-technology-company AI licensing project disclosed in fiscal 2025 results; exact titles and corpus size undisclosed.
Wiley role · Provider / asset owner
- Provider / asset owner — Wiley
- AI recipient — Undisclosed third large technology company
- Strategic buyer or operator — Undisclosed third large technology company
Recorded status · announced historical backfill. Last reviewed Nov 18, 2026.
Access · corpus delivery. Training rights · not disclosed.
Disclosed economics · Compensation or a revenue opportunity is stated; no recipient-specific amount is established. Scope · No data-license value is estimated. Aggregate corporate revenue, financing valuations, settlement payments and catalogue capacity are not treated as this arrangement’s price.
Evidence
May 8, 2025 · Governed access
Wiley → Perplexity
Wiley scholarly and educational content integrated into AI search with attribution and sourced citations.
Wiley role · Provider / asset owner
- Provider / asset owner — Wiley
- AI recipient — Perplexity
Recorded status · announced. Last reviewed Nov 18, 2026.
Access · retrieval. Training rights · not disclosed.
Disclosed economics · Not disclosed
Evidence
- newsroom.wiley.com · primary